Dexmedetomidine Versus Midazolam for End-of-Life Sedation: The DREAMS Non-Blinded Randomized Clinical Trial

This publication has 32 references indexed in Scilit:

• Emergency Palliative Cancer Care: Dexmedetomidine Treatment Experiences—A Retrospective Brief Report on Nine Consecutive Cases
  Pain and Therapy, 2023
• Subcutaneously administered dexmedetomidine is efficiently absorbed and is associated with attenuated cardiovascular effects in healthy volunteers
  European Journal of Clinical Pharmacology, 2018
• Clinical Assessment and Management of Delirium in the Palliative Care Setting
  Drugs, 2017
• Benzodiazepine-associated delirium in critically ill adults
  Intensive Care Medicine, 2015
• Dexmedetomidine vs Midazolam or Propofol for Sedation During Prolonged Mechanical Ventilation
  JAMA, 2012
• Dexmedetomidine vs Midazolam for Sedation of Critically Ill PatientsA Randomized Trial
  JAMA, 2009
• Family Perspectives on End-of-Life Care at the Last Place of Care
  JAMA, 2004
• Clinical utility, factor analysis, and further validation of the memorial delirium assessment scale in patients with advanced cancer
  Cancer, 2000
• Sedation in the Intensive Care Unit
  JAMA, 2000
• Subcutaneous midazolam infusion in palliative care
  Journal of Pain and Symptom Management, 1990